CD4 Cell Count at Antiretroviral Therapy Initiation or Re- Initiation

The primary purpose of this study is to assess the burden of advanced HIV disease (CD4 cell count \<200 or \<350 cells/μL) among new patients and those returning to care after a gap in treatment, and the extent to which low coverage of CD4 cell count measurement among these patients may prevent adequate management of those with advanced HIV disease.

NCT Number	NCT07760324
Lead Sponsor	Centre for Infectious Disease Research in Zambia
Conditions	HIV - Human Immunodeficiency Virus
Enrollment	151 participants
Start Date	2024-11-28
Primary Completion	2027-12 (estimated)
Study Completion	2028-03 (estimated)
Updated on ClinicalTrials.gov	2026-08-12